Dynamic42 interviewed by OTZ

16. November 2020 In News

Dynamic42 interviewed by OTZ

In the run-up to the award ceremony for the XXIII Thuringian Innovation Prize, we were interviewed by the Ostthüringer Zeitung newspaper about our development, with which we managed to make it into the top 20. Read the complete interview here.

Press Release | Tumour-on-chip model supports preclinical drug development on pancreatic cancer

Dynamic42 and Heinrich Heine University have developed a tumour-on-a-chip model that replicates the microenvironment of pancreatic ductal adenocarcinoma (PDAC). This 3D model allows for realistic drug testing and could accelerate the development of personalized therapies.

Press Release | Dynamic42 and research partners present three-organ system to reduce animal testing

Dynamic42, in collaboration with ESQlabs, Bayer, and the Placenta Lab, has developed an innovative three-organ system with the potential to reduce animal testing in pharmaceutical research.